Contraceptive methods are used to prevent pregnancy and sexually transmitted infections (STIs).
Contraception allows women/couples to explore plan on childbearing and family planning.
Hormonal contraception is a method with high rate of effectiveness & ease of administration. It is the widely used method of reversible contraception.
It does not protect against STIs/HIV.


  • Contraceptive methods are used to prevent pregnancy and sexually transmitted infections (STIs)
  • Contraception allows women/couples to explore plans on childbearing and family planning
  • Contraceptive care and access are parts of the reproductive and sexual health care that the World Health Organization (WHO) recognizes as a fundamental human right
  • The Platform for Action of the 1995 Beijing Conference stated:

 “The basic right of all couples and individuals to decide freely and responsibly the number and spacing and timing of their children and to have the information and means to do so, and the right to attain the highest standard of sexual and reproductive health”

Determinants of Effective Contraceptive Method

Information Provided by Health Care Providers

  • Birth control options and their effectiveness
  • Specific characteristics of the contraceptive method
  • Common adverse effects
  • Balance between risks and benefits of the method
  • Instructions on the correct use of the chosen method
  • Actions to be taken in case problems arise
  • Strategies to help with consistent use of a specific method over time
  • Information to avoid STIs

Woman’s Attitude Towards Specific Method

  • Openness in discussing contraception with the physician and partner on personal perception or matters concerning sexuality
  • The woman’s perception on what method is accepted or rejected by partner, relatives, or society as a whole, greatly influences her choice and compliance

Specific Behavioral Skills

  • Formulation of contraceptive health agenda

Environmental Factors

  • Healthcare worker should consider factors that may lessen the ability of the woman to use method effectively
    • Eg women in abusive or disempowered relationships, cost of contraception, those who are chemically dependent, etc



  • A method with high rate of effectiveness and ease of administration
  • Widely used method of reversible contraception
  • Does not protect against sexually transmitted infections/human immunodeficiency virus (STIs/HIV)
    • For high-risk individuals, the correct and consistent use of condoms is recommended, either alone or with another contraceptive method

Combined Hormonal Contraception

  • Refers to methods that contain both Estrogen and Progestin
  • Progestin component inhibits ovulation and thickens the cervical mucus
  • Estrogen component inhibits follicular development, maintains the endometrium and prevents unscheduled bleeding
  • Initiation of combined hormonal contraception should be done immediately

Progestin-only Hormonal Contraception

  • May be used in women who require Estrogen-free method of contraception and/or in those who may benefit from the non-contraceptive activity of Progestin
  • May be used with caution in women with proven thrombophilia
  • Can be used in women with current, previous history or family history of venous thromboembolism (VTE), on anticoagulants, known thrombogenic mutations, or in those who underwent minor or major surgery with or without prolonged immobilization
  • Can be initiated in women with history of stroke or myocardial infarction (MI) as no causal association has been observed, however, should be discontinued once patient develops new symptoms of stroke or heart disease
  • May be given to women regardless of weight [eg body mass index (BMI) ≥30 kg/m2]
  • Women who may benefit from Estrogen-free contraception:
    • Women >35 years who smoke, have migraines, are recently postpartum and those who are breastfeeding
  • Counsel patient regarding disturbances in menstrual cycle before starting progestin-only hormonal contraception

Types of Contraceptive Failure

  • User failure: Pregnancy occurs due to incorrect use or non-use of hormonal contraception
  • Method failure: Pregnancy occurs despite the method of contraception being used correctly and consistently

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Editor's Recommendations
Most Read Articles
27 Nov 2017
Transdermal oestradiol added to progesterone reduces menopause-related depression, researchers reported at the annual meeting of The North American Menopause Society in Philadelphia, US.
Tracy TC Kwan, BSc (Nursing), MPH; Hextan YS Ngan, MBBS, FHKAM (O&G), MD (HK), FRCOG, 01 Aug 2013

Human papillomavirus (HPV) infection is a prevalent disease worldwide. Consequences of HPV infection vary, depending on the infected individuals and the HPV genotype involved. Life-threatening consequences are not uncommon, and cervical cancer is a clear demonstration of the virus’s potency. While the incidence of cervical cancer is heavily concentrated on developing countries,1 the impact of HPV-related diseases on developed countries has not ceased. In the United States alone, HPV infections are the most common sexually transmitted disease with an estimated 5 million new cases being diagnosed in 2000 among young adults, incurring nearly US$3 billion in terms of direct medical costs.2 A multinational study involving 18,498 women showed that cervical HPV prevalence varied greatly geographically, ranging from the low of 1.6% in North Vietnam to the high of 27% in Nigeria. In general, HPV prevalence peaked among young, sexually active women and declined with age. In selected countries, however, a second peak was noted in women older than 55 years.3 The high prevalence of HPV-related diseases incurs a heavy burden on the healthcare systems of developed and developing countries alike, which renders HPV research and prevention a global public health imperative. On an individual level, the afflictions caused by HPV-related diseases go beyond that of physical suffering to affecting the psychological well-being of the infected. This is the focus of our paper.

27 Nov 2017
Chronic hepatitis B virus (HBV) infection is a global problem. Chronic HBV infection is probably the most common maternal infection encountered in Hong Kong, China, and Southeast Asia. In Hong Kong, which is one of the endemic areas, immunisation against HBV was first provided in 1983 to infants born to mothers who were screened positive for hepatitis B surface antigen (HBsAg). Immunisation became widespread since November 1988, but HBsAg-positive mothers are still encountered frequently.1
GC Kang, VK Yeow, 01 Feb 2015

Craniofacial abnormalities affect a significant proportion of society. Cleft lip and/or palate, for example, occurs in 1 per 500–700 births, depending on geography and ethnicity. The costs in terms of morbidity, psychological disturbance, and social and workplace exclusion are considerable for patients and their families, and society. The average incidence of new cleft cases is 2 clefts per 1,000 live births in the combined populations of Thailand, Bangladesh, Bhutan, Brunei, Cambodia, Indonesia, Laos, Malaysia, Nepal, Pakistan, Philippines, Singapore, Sri Lanka, and Vietnam.1